Brief: Neovacs FY Net Loss Narrows To 7.5 Million Euros
July 13 - NEOVACS SA ALNEV.PA :
* PUBLISHED ON SUNDAY FY RESULTS RELATING TO THE PERIOD
PRECEDING
THE IMPLEMENTATION OF THE CONTINUATION PLAN
* FY NET LOSS EUR 7.5 MLN, UP BY EUR 3.2 MLN YOY
* FY OPERATING LOSS EUR 8.2 MLN, UP BY EUR 4.9 MLN YOY
* END-FY NET CASH OF EUR 1.2 MLN
* DATA FOR THE 2019 FINANCIAL YEAR ARE NOT REPRESENTATIVE OF
THE
NEW ORIENTATION OF NEOVACS
Source text for Eikon: urn:newsml:reuters.com:*:nACT64253
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants